Completed PHASE4 INTERVENTIONAL 2-arm NCT01670786

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Sponsor: Grupo de Pesquisa em Pleura e Oncologia Toracica

Interventions pleurodesis

Updated 5 times since 2017 Last updated: May 12, 2014 Started: Jan 31, 2010 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01670786, this PHASE4 trial focuses on Pleural Effusion, Malignant and remains completed. Sponsored by Grupo de Pesquisa em Pleura e Oncologia Toracica, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grupo de Pesquisa em Pleura e Oncologia Toracica
Instituto do Cancer do Estado de São Paulo
Instituto do Coracao

Data source: Grupo de Pesquisa em Pleura e Oncologia Toracica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salvador, Brazil